About Cyma Life Sciences Private Limited
Data last updated:
Cyma Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 July 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2007PTC054924.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.5 Cr. It is led by directors including Sudha Rani Balusu and Narendra Balusu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 8 – 4 – 376/14 New Sastry Nagar Sanath Nagar, Hyderabad, Telangana, India – 500018.
As per the financials filed for FY 2024, the company reported a revenue of ₹15.02 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹34.78 Lakh (net margin 2.3%) and EBITDA of ₹1.61 Cr (EBITDA margin 10.7%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 17% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹9.48 Cr and satisfied charges of ₹7.72 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cymalife.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address8 – 4 – 376/14 New Sastry Nagar Sanath Nagar, Hyderabad, Telangana, India – 500018
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Cyma Life Sciences Private Limited
The main business activity of Cyma Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Cyma Life Sciences Private Limited FY 2025 filings available
Cyma Life Sciences Private Limited reported revenue of ₹15.02 Cr (down 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Cyma Life Sciences Private Limited
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Cyma Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.61 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹34.78 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Cyma Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cyma Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Cyma Life Sciences Private Limited
Cyma Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cornileus Pharmaceuticals Private Limited | ₹16.06 Cr (FY 2024) | •••• | •••• | -60.0% | •••• | Hyderabad, Telangana, India |
| Shilpa Chemspec International Private Limited | ₹15.42 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Mumbai, Maharashtra, India |
| Gomti Research and Pharmachem Private Limited | ₹15.27 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Bangalore, Karnataka, India |
| Mithila Drugs Private Limited | ₹15.27 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Udaipur, Rajasthan, India |
| Prizam Alliance Private Limited | ₹15.2 Cr (FY 2023) | •••• | •••• | •••• | Surat, Gujarat, India | |
| Cyma Life Sciences Private Limited this company | ₹15.02 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Hyderabad, Telangana, India |
| Rasino Drugs Private Limited | ₹14.98 Cr (FY 2024) | •••• | •••• | -9.0% | •••• | Ambernath, Maharashtra, India |
| Grindlays Pharmaceuticals Pvt Ltd | ₹14.96 Cr (FY 2025) | •••• | •••• | 69.0% | •••• | Mumbai, Maharashtra, India |
| Phyto Ingredients Biopharma Private Limited | ₹14.72 Cr (FY 2025) | •••• | •••• | 159.0% | •••• | Bahadurgarh, Haryana, India |
| Chorus Labs Limited | ₹14.67 Cr (FY 2025) | •••• | •••• | -33.0% | •••• | Hyderabad, Telangana, India |
| Paras Organics Private Limited | ₹14.64 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Cyma Life Sciences by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Cyma Life Sciences Private Limited
Cyma Life Sciences Private Limited is audited by DARAPANENI & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DARAPANENI & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Cyma Life Sciences Private Limited
Cyma Life Sciences has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudha Rani Balusu Also directs: Nanda Nandana Estates & Farms Private Limited | Director | 01 Apr 2014 | 12 Years 6 Months | Current |
| Narendra Balusu | Director | 11 Jun 2008 | 18 Years 3 Months | Current |
| Lakshmana Swamy Balusu | Director | 27 May 2008 | 18 Years 4 Months | Current |
| Sai Phani Teja Balusu | Director | 13 Oct 2021 | 4 Years 11 Months | Current |
Ownership and Shareholding of Cyma Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Cyma Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2024 | Others | ₹4.5 Cr | Open |
| 29 Oct 2018 | Others | ₹4.98 Cr | Open |
| 20 Oct 2010 | State Bank of India | ₹2.74 Cr | Satisfied |
| 18 Aug 2009 | State Bank of India | ₹4.98 Cr | Satisfied |
Total charge records: 4 View all charges
Legal Cases of Cyma Life Sciences Private Limited
Cyma Life Sciences Private Limited has 1 court case on record: 1 filed by Cyma Life Sciences. All case is disposed. Status as checked on 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Writ petition | Filed by the company against Central Power Distribution Company of A.P. Ltd | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Cyma Life Sciences Private Limited
Cyma Life Sciences Private Limited has a workforce of 8 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Cyma Life Sciences Private Limited
Cyma Life Sciences has one previous CIN (Corporate Identification Number): U24232AP2007PTC054924. The current CIN is U24232TG2007PTC054924, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2007PTC054924 | Current |
| U24232AP2007PTC054924 | Previous |
Recent Activity on Cyma Life Sciences Private Limited
Cyma Life Sciences Private Limited has 8 board changes on record since 2007: 6 appointments and 2 cessations. The latest: Sai Phani Teja Balusu was appointed as Director on 13 Oct 2021.
6 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Cyma Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cyma Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cyma Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cyma Life Sciences Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cyma Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cyma Life Sciences Private Limited
Cyma Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 July 2007 (19+ years old) and is registered under CIN U24232TG2007PTC054924.
Cyma Life Sciences reported revenue of ₹15.02 Cr for FY 2024 (down 6% YoY).
Cyma Life Sciences has 4 current directors:
- Sudha Rani Balusu - Director
- Narendra Balusu - Director
- Lakshmana Swamy Balusu - Director
- Sai Phani Teja Balusu - Director
Cyma Life Sciences reported a net profit of ₹34.78 Lakh (net margin 2.3%) and EBITDA of ₹1.61 Cr (EBITDA margin 10.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Cyma Life Sciences is 2% over three years and 17% over five years. In the latest year (FY 2024) revenue fell 6%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Cyma Life Sciences is U24232TG2007PTC054924. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cyma Life Sciences has 1 court case on record: 1 filed by the company.
Cyma Life Sciences was incorporated on 27 July 2007, making it 19+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Cyma Life Sciences by revenue are Cornileus Pharmaceuticals Private Limited, Shilpa Chemspec International Private Limited, Gomti Research and Pharmachem Private Limited, Mithila Drugs Private Limited, Prizam Alliance Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Sai Phani Teja Balusu was appointed as Director on 13 Oct 2021. Sudha Rani Balusu was appointed as Director on 01 Apr 2014. Sanjay Chillakuru Reddy ceased to be Director on 06 Nov 2008. Cyma Life Sciences has 8 board changes on record in total.
Cyma Life Sciences can be reached through the website cymalife.com. Its registered office is in Hyderabad, Telangana, India.